Empagliflozin Induces White Adipocyte Browning and Modulates Mitochondrial Dynamics in KK Cg-Ay/J Mice and Mouse Adipocytes
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Empagliflozin Induces White Adipocyte Browning and Modulates Mitochondrial Dynamics in KK Cg-Ay/J Mice and Mouse Adipocytes
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-10-27
DOI
10.3389/fphys.2021.745058
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial
- (2020) João Pedro Ferreira et al. Cardiovascular Diabetology
- Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet
- (2019) Liang Xu et al. BMJ Open Diabetes Research & Care
- The integrative biology of type 2 diabetes
- (2019) Michael Roden et al. NATURE
- Mitochondrial dysfunction in obesity
- (2018) Aline Haas de Mello et al. LIFE SCIENCES
- The Common and Distinct Features of Brown and Beige Adipocytes
- (2018) Kenji Ikeda et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- AMP-Activated Protein Kinase (AMPK) Regulates Energy Metabolism through Modulating Thermogenesis in Adipose Tissue
- (2018) Lingyan Wu et al. Frontiers in Physiology
- Emerging Role of AMPK in Brown and Beige Adipose Tissue (BAT): Implications for Obesity, Insulin Resistance, and Type 2 Diabetes
- (2018) Eric M. Desjardins et al. Current Diabetes Reports
- Effect of sodium-glucose cotransporter 2 inhibitor, empagliflozin, and α-glucosidase inhibitor, voglibose, on hepatic steatosis in an animal model of type 2 diabetes
- (2018) Ji-Won Kim et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Pharmacotherapy of obesity: Available medications and drugs under investigation
- (2018) Eleni Pilitsi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
- (2017) Sebastian Steven et al. Redox Biology
- SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
- (2017) Liang Xu et al. EBioMedicine
- Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: Focus on fat browning and macrophage polarization
- (2017) Liang Xu et al. Adipocyte
- Fixed-Dose Combination of Canagliflozin and Metformin for the Treatment of Type 2 Diabetes: An Overview
- (2016) Jaime A. Davidson et al. ADVANCES IN THERAPY
- Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome
- (2016) Hiroaki Kusaka et al. Cardiovascular Diabetology
- Lack of Adipocyte AMPK Exacerbates Insulin Resistance and Hepatic Steatosis through Brown and Beige Adipose Tissue Function
- (2016) Emilio P. Mottillo et al. Cell Metabolism
- Role of developmental transcription factors in white, brown and beige adipose tissues
- (2015) Catriona Hilton et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Impaired Mitochondrial Biogenesis in Adipose Tissue in Acquired Obesity
- (2015) Sini Heinonen et al. DIABETES
- Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
- (2015) R. Chilton et al. DIABETES OBESITY & METABOLISM
- Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections of Insulin in Obese Inadequately Controlled Type 2 Diabetes
- (2014) Julio Rosenstock et al. DIABETES CARE
- Mitochondrial Fission and Fusion in Human Diseases
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- White-to-brown transdifferentiation of omental adipocytes in patients affected by pheochromocytoma
- (2013) Andrea Frontini et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Mitochondrial Dynamics in the Regulation of Nutrient Utilization and Energy Expenditure
- (2013) Marc Liesa et al. Cell Metabolism
- Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes: A 24-week, randomized, double-blind, placebo-controlled trial
- (2013) H.-U. Haring et al. DIABETES CARE
- Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial
- (2013) C. S. Kovacs et al. DIABETES OBESITY & METABOLISM
- Adipose tissue browning and metabolic health
- (2013) Alexander Bartelt et al. Nature Reviews Endocrinology
- Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
- (2012) Jun Wu et al. CELL
- Altered Mitochondrial Dynamics Contributes to Endothelial Dysfunction in Diabetes Mellitus
- (2011) Sherene M. Shenouda et al. CIRCULATION
- Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1
- (2010) Chuang-Rung Chang et al. Annals of the New York Academy of Sciences
- Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network
- (2010) Richard C. Scarpulla BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Distribution and Development of Brown Adipocytes in the Murine and Human Adipose Organ
- (2010) Andrea Frontini et al. Cell Metabolism
- Mitochondrial Fusion Is Increased by the Nuclear Coactivator PGC-1β
- (2008) Marc Liesa et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started